Nosocomial meningitis in children after ventriculoperitoneal shunt insertion

Acta Paediatr. 1999 May;88(5):576-8. doi: 10.1080/08035259950169620.

Abstract

This study reviews 33 cases of ventriculoperitoneal shunt (VPS) meningitis among 415 children after 540 shunt insertions within 8 y, in 9 paediatric intensive care units from 5 centres in Slovakia. The incidence of VPS meningitis was 6.3% per insertion. The most common organisms isolated from cerebrospinal fluid (CSF) and shunt were coagulase-negative staphylococci (52.8%), followed by Staphylococcus aureus (13.1%) and Pseudomonas aeruginosa (7.5%). Seven of 15 assessed risk factors were significantly associated with VPS meningitis, compared with non-VPS meningitis: prior meningitis with hydrocephalus (15.1 vs 1.5%, p < 0.015), perinatal pathology (51.1 vs 1.5%, p < 0.001), very low birthweight (66.6 vs 16.2%, p < 0.001), polymicrobial nosocomial meningitis (30.3 vs 5.9%, p < 0.002), S. aureus (21.2 vs 7.3%, p < 0.05), coagulase-negative staphylococci (84.8 vs 30.9%, p < 0.001) and P. aeruginosa and Acinetobacter calcoaceticus (30.3 vs 4.5%, p < 0.001) in aetiology.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Infective Agents / therapeutic use*
  • Ceftazidime / therapeutic use*
  • Cephalosporins / therapeutic use*
  • Ciprofloxacin / therapeutic use*
  • Cross Infection / complications*
  • Humans
  • Infant
  • Infant, Newborn
  • Meningitis, Bacterial / drug therapy*
  • Meningitis, Bacterial / microbiology*
  • Postoperative Complications / drug therapy*
  • Retrospective Studies
  • Risk Factors
  • Vancomycin / therapeutic use*
  • Ventriculoperitoneal Shunt*

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Cephalosporins
  • Ciprofloxacin
  • Vancomycin
  • Ceftazidime